Antidiabetic drugs and oxidized low-density lipoprotein: A review of anti-atherosclerotic mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antidiabetic drugs and oxidized low-density lipoprotein: A review of anti-atherosclerotic mechanisms
Authors
Keywords
Atherosclerosis, Cardiovascular disease, Diabetes, Oxidized LDL
Journal
PHARMACOLOGICAL RESEARCH
Volume 172, Issue -, Pages 105819
Publisher
Elsevier BV
Online
2021-08-14
DOI
10.1016/j.phrs.2021.105819
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
- (2021) Maria Mirabelli et al. Journal of Clinical Medicine
- The Effects of SGLT2 Inhibitors on Lipid Metabolism
- (2021) Zsolt Szekeres et al. Metabolites
- Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis
- (2021) Thijs J. Sluiter et al. Biomedicines
- Pro-fibrotic effect of oxidized LDL in cardiac myofibroblasts
- (2020) Monica Villa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
- (2020) Anastasia Poznyak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Electronegative LDL Promotes Inflammation and Triglyceride Accumulation in Macrophages
- (2020) Núria Puig et al. Cells
- Effect of Repaglinide on Blood Glucose, Endothelial Function, Lipid Metabolism, and Inflammatory Reaction in a Rat Model of Atherosclerosis
- (2020) Jie Chang et al. Dose-Response
- Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice
- (2020) Byambasuren Ganbaatar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression
- (2020) Michishige Terasaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium
- (2020) Donato Cappetta et al. PHARMACOLOGICAL RESEARCH
- MicroRNA-128-1-5p attenuates myocardial ischemia/reperfusion injury by suppressing Gadd45g-mediated apoptotic signaling
- (2020) Xiaoya Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
- (2020) Kai-Cheng Chang et al. Cardiovascular Diabetology
- Metformin Should Not Be Used to Treat Prediabetes
- (2020) Mayer B. Davidson DIABETES CARE
- Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes
- (2020) C.C. Berra et al. PHARMACOLOGICAL RESEARCH
- DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation
- (2020) Haoran Wang et al. Drug Design Development and Therapy
- Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
- (2020) Nordin M. J. Hanssen et al. Frontiers in Cardiovascular Medicine
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB
- (2019) Suxia Ma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study
- (2019) Giovanni Sartore et al. ACTA DIABETOLOGICA
- The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats
- (2019) Grażyna Wójcicka et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The GLP1 Receptor Agonist Liraglutide Protects Against Oxidized LDL‐Induced Endothelial Inflammation and Dysfunction via KLF2
- (2019) Wen Yue et al. IUBMB LIFE
- Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ
- (2019) Saiko Murakami-Nishida et al. ATHEROSCLEROSIS
- Canagliflozin for Japanese patients with chronic heart failure and type II diabetes
- (2019) Akira Sezai et al. Cardiovascular Diabetology
- Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice
- (2019) Kentaro Mori et al. Cardiovascular Diabetology
- Metformin improved oxidized low-density lipoprotein-impaired mitochondrial function and increased glucose uptake involving Akt-AS160 pathway in raw264.7 macrophages
- (2019) Xuan He et al. CHINESE MEDICAL JOURNAL
- Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A
- (2019) Lei Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Peroxisome Proliferator-Activated Receptor-γ Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p
- (2019) Lei Xu et al. PPAR Research
- DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs
- (2019) Jianqiang Zhang et al. Frontiers in Immunology
- Clinical Use of DPP-4 Inhibitors
- (2019) Baptist Gallwitz Frontiers in Endocrinology
- Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice
- (2019) Georgios K. Dimitriadis et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- 30-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study
- (2019) Alessandra Schiapaccassa et al. Diabetology & Metabolic Syndrome
- Thiazolidinediones: the Forgotten Diabetes Medications
- (2019) Harold E. Lebovitz Current Diabetes Reports
- Sitagliptin favorably modulates immune-relevant pathways in human beta cells
- (2019) Amir Mohammad Malvandi et al. PHARMACOLOGICAL RESEARCH
- Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
- (2019) Alana Aragón-Herrera et al. BIOCHEMICAL PHARMACOLOGY
- Mechanisms and Characteristics of Sulfonylureas and Glinides
- (2019) Wei Lv et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis
- (2019) Wei Chang et al. MOLECULAR IMMUNOLOGY
- An overview of GLP-1 agonists and recent cardiovascular outcomes trials
- (2019) Kelsey H Sheahan et al. POSTGRADUATE MEDICAL JOURNAL
- Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity
- (2018) Surya Ramachandran et al. CLINICAL SCIENCE
- Incretins and Lipid Metabolism
- (2018) Vasilis Tsimihodimos et al. CURRENT MEDICINAL CHEMISTRY
- Metformin, lipids and atherosclerosis prevention
- (2018) Alicia J. Jenkins et al. CURRENT OPINION IN LIPIDOLOGY
- DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2018) Qixian Wang et al. Journal of Diabetes Research
- Endoplasmic Reticulum Stress Affects Lipid Metabolism in Atherosclerosis Via CHOP Activation and Over-Expression of miR-33
- (2018) Yan Sun et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Metformin ameliorates Ox-LDL-induced foam cell formation in raw264.7 cells by promoting ABCG-1 mediated cholesterol efflux
- (2018) Xuan He et al. LIFE SCIENCES
- Glucagon-like peptide-1 receptor action in the vasculature
- (2018) Malak Almutairi et al. PEPTIDES
- Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression
- (2018) Fei Kong et al. BIOMEDICINE & PHARMACOTHERAPY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients
- (2018) Michishige Terasaki et al. International Journal of Endocrinology
- Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
- (2017) Yoon Oh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice
- (2017) Yusuke Nakatsu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mechanisms of foam cell formation in atherosclerosis
- (2017) Dimitry A. Chistiakov et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- I 4 , a synthetic anti-diabetes agent, attenuates atherosclerosis through its lipid-lowering, anti-inflammatory and anti-apoptosis properties
- (2017) Lingman Ma et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis
- (2017) Koichiro Homma et al. Drugs in research & development
- CD40 in coronary artery disease: a matter of macrophages?
- (2016) Matthijs F. Jansen et al. BASIC RESEARCH IN CARDIOLOGY
- Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In VivoNovelty and Significance
- (2016) Zhejun Cai et al. CIRCULATION RESEARCH
- Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
- (2016) William Herrington et al. CIRCULATION RESEARCH
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr −/− mice
- (2016) Amanda Karolina Soares e Silva et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+/K+channel flow
- (2016) Jinyu Su et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release
- (2016) Tania Romacho et al. JOURNAL OF HYPERTENSION
- Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
- (2016) Young-Sun Lee et al. MEDIATORS OF INFLAMMATION
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis
- (2016) Shi-jie Zhao et al. PLoS One
- Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling
- (2016) Ching-Hsia Hung et al. Oncotarget
- The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification
- (2016) Amber M. Kay et al. Journal of Diabetes Research
- State of the art paper Sulfonylureas and their use in clinical practice
- (2015) Daniele Sola et al. Archives of Medical Science
- Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
- (2015) Feng Sun et al. CLINICAL THERAPEUTICS
- Incretin-based therapies for obesity treatment
- (2015) Aline Haas de Mello et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus
- (2015) Agnieszka Strózik et al. Pharmacological Reports
- Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation
- (2015) Seung Hee Choi et al. VASCULAR PHARMACOLOGY
- Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
- (2015) Yuichi Terawaki et al. Diabetology & Metabolic Syndrome
- Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice
- (2015) Michishige Terasaki et al. PLoS One
- The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome
- (2014) Ayse Carlioglu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Is atherosclerosis an autoimmune disease?
- (2014) Eiji Matsuura et al. BMC Medicine
- DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
- (2014) Yao Dai et al. CARDIOVASCULAR DRUGS AND THERAPY
- Treg/Th17 Ratio Acts as a Novel Indicator for Acute Coronary Syndrome
- (2014) Qing Li et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- OxLDL induces endothelial dysfunction and death via TRAF3IP2: Inhibition by HDL3 and AMPK activators
- (2014) Anthony J. Valente et al. FREE RADICAL BIOLOGY AND MEDICINE
- The ATP-Sensitive Potassium Channel Subunit, Kir6.1, in Vascular Smooth Muscle Plays a Major Role in Blood Pressure Control
- (2014) Qadeer Aziz et al. HYPERTENSION
- Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the development of THP-1 derived foam cells
- (2014) Hong-Yan Liu et al. JOURNAL OF BIOCHEMISTRY
- GLP-1 Agonists Inhibit ox-LDL Uptake in Macrophages by Activating Protein Kinase A
- (2014) Yao Dai et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- No Improvement of High-Density Lipoprotein (HDL) Vasorelaxant Effect Despite Increase in HDL Cholesterol Concentration in Type 2 Diabetic Patients Treated With Glitazones
- (2014) Laurence Perségol et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
- (2014) Yuko Tashiro et al. PEPTIDES
- Mechanism linking diabetes mellitus and obesity
- (2014) Abdullah Algoblan et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway
- (2013) Yao Dai et al. ACTA DIABETOLOGICA
- Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ
- (2013) Yao Dai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells
- (2013) Yao Dai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immunity, atherosclerosis and cardiovascular disease
- (2013) Johan Frostegård BMC Medicine
- Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
- (2013) Y Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis
- (2013) Yanlin Yin et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension
- (2013) Lyubov Chaykovska et al. JOURNAL OF HYPERTENSION
- Diabetes Mellitus-Associated Vascular Impairment
- (2013) Dimitris Tousoulis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
- (2013) Michishige Terasaki et al. PLoS One
- Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease
- (2013) Morihiro Matsuda et al. Diabetology & Metabolic Syndrome
- Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages
- (2013) Bobae Hyun et al. Immune Network
- Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials
- (2012) Matteo Monami et al. ADVANCES IN THERAPY
- Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
- (2012) Aaron S Kelly et al. Cardiovascular Diabetology
- PKCδ signalling regulates SR-A and CD36 expression and foam cell formation
- (2012) Chin-Sheng Lin et al. CARDIOVASCULAR RESEARCH
- Kruppel-Like Factors and Vascular Inflammation: Implications for Atherosclerosis
- (2012) Mohamad Amer Alaiti et al. Current Atherosclerosis Reports
- Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe −/− mice
- (2012) F. Vittone et al. DIABETOLOGIA
- Effect of Advanced Glycation End Products on Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 Expression in Endothelial Cells
- (2012) Sammy WM Shiu et al. Journal of Atherosclerosis and Thrombosis
- Effects of PKF275-055, a dipeptidyl peptidase–4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E–null mice
- (2012) Michishige Terasaki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy
- (2011) Sona Mitra et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells
- (2011) Yan Shen et al. ATHEROSCLEROSIS
- Oxidized LDL, LOX-1 and Atherosclerosis
- (2011) Sona Mitra et al. CARDIOVASCULAR DRUGS AND THERAPY
- Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- (2011) Zubair Shah et al. CIRCULATION
- Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison
- (2011) Jun-Sing Wang et al. CLINICAL THERAPEUTICS
- Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
- (2011) M. Nagashima et al. DIABETOLOGIA
- Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway
- (2011) Fu-qiang Liu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase
- (2011) Virginia Guarani et al. NATURE
- Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
- (2011) Maria Vinaixa et al. PLoS One
- Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients
- (2011) Manouchehr Nakhjavani et al. REDOX REPORT
- Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
- (2011) Gian Paolo Fadini et al. VASCULAR PHARMACOLOGY
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- Activation of AMP-Activated Protein Kinase Inhibits Oxidized LDL-Triggered Endoplasmic Reticulum Stress In Vivo
- (2010) Y. Dong et al. DIABETES
- Thiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor γ-Independent Pathway
- (2010) Yusuke Higashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient mice
- (2010) Patrizia Nigro et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- (2010) Faramarz Ismail-Beigi et al. LANCET
- Oxidized Low-Density Lipoprotein Inhibits Nitric Oxide-Mediated Coronary Arteriolar Dilation by Up-regulating Endothelial Arginase I
- (2010) WEI WANG et al. MICROCIRCULATION
- Macrophage Apoptosis in Atherosclerosis: Consequences on Plaque Progression and the Role of Endoplasmic Reticulum Stress
- (2009) Ira Tabas ANTIOXIDANTS & REDOX SIGNALING
- Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)
- (2009) Nancy A. Thornberry et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Postprandial hyperglycemia as an etiological factor in vascular failure
- (2009) Koichi Node et al. Cardiovascular Diabetology
- Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?
- (2009) N. Papanas et al. CURRENT PHARMACEUTICAL DESIGN
- Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study
- (2009) Omer T. Njajou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Macrophage cholesteryl ester mobilization and atherosclerosis
- (2009) Shobha Ghosh et al. VASCULAR PHARMACOLOGY
- The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells
- (2008) Ling Li et al. ATHEROSCLEROSIS
- The α-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes
- (2008) Goji Hasegawa et al. CLINICA CHIMICA ACTA
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes
- (2007) Antonio Ceriello et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started